Preferred Label : abaloparatide;

CISMeF synonym : BA058;

UNII : AVK0I6HY2U;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3574250/fr/eladynos-abaloparatide-osteoporose
2025
false
false
false
France
abaloparatide
Product containing only abaloparatide in parenteral dose form (medicinal product form)
treatment outcome
insurance, health, reimbursement
osteoporotic fractures
History of vertebral fracture (situation)
History of osteoporotic fracture (situation)
injections, subcutaneous
bone density conservation agents
evaluation of the transparency committee
osteoporosis, postmenopausal
abaloparatide

---
https://www.ema.europa.eu/en/medicines/human/EPAR/eladynos
2023
false
false
false
Netherlands
French
English
treatment outcome
drug evaluation
abaloparatide
abaloparatide
summary of product characteristics
package leaflet
syndication feed
abaloparatide
drug approval
europe
osteoporosis, postmenopausal
osteoporotic fractures
injections, subcutaneous
bone density conservation agents
bone density conservation agents
product surveillance, postmarketing
drug interactions
drug evaluation, preclinical
parathyroid hormone-related protein

---
https://www.cadth.ca/fr/abaloparatide
2022
false
false
false
Canada
French
drug evaluation
canada
abaloparatide
bone density conservation agents
abaloparatide

---
Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.